Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New “triggered-release” mechanism could improve drug delivery

By Drug Discovery Trends Editor | January 16, 2015

Image: Univ. of WarwickMore efficient medical treatments could be developed thanks to a new method for triggering the rearrangement of chemical particles.

The new method, developed at the Univ. of Warwick, uses two “parent” nanoparticles that are designed to interact only when in proximity to each other and trigger the release of drug molecules contained within both.

The release of the drug molecules from the “parent” nanoparticles could subsequently form a third “daughter” particle, which comprises molecules from both “parent” nanoparticles.

The researchers, led by Profs. Andrew Dove and Rachel O’Reilly, suggest that this new mechanism could potentially limit side-effects by only releasing the drug where required.

“We conceive that in the blood stream the particles would not be able to interact sufficiently to lead to release, only when they are taken into cells would the release be able to happen,” says Prof. Dove. “In this way, the drug can be targeted to only release where we want it to and therefore be more effective and reduce side effects.”

The chemical composition of the two ‘parent’ nanoparticles is crucial to the new method. Prof. Dove explains, “The two ‘parent’ nanoparticles used in the new mechanism are cylindrical in shape and are made from polymer chains that differ only by the way in which chemical bonds are directed within a part of the structure.

“When the two ‘parent’ nanoparticles are in close enough proximity the polymer chains are driven to come together to form a new ‘daughter’ nanoparticle by a phenomenon known as stereocomplexation.

“In the process of this rearrangement, we propose that any molecules, such as drug molecules, that are encapsulated within the parent particles will be released.”

Published in Nature Communications the research could “raise new possibilities in how we can administer medical treatments,” says Prof. Dove. “We’re planning to study this as a new treatment for cancer but the principle could potentially be applied to a wide range of diseases.”

Source: Univ. of Warwick


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE